| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 88374 |
|
19,410 |
10,527 |
$1.83M |
| 88185 |
|
11,388 |
8,155 |
$1.39M |
| 88184 |
|
9,176 |
8,158 |
$314K |
| 88237 |
|
5,217 |
3,568 |
$223K |
| 88341 |
|
3,468 |
3,008 |
$201K |
| 88377 |
|
2,673 |
1,884 |
$174K |
| 88361 |
|
2,890 |
2,384 |
$132K |
| 88189 |
|
4,867 |
4,433 |
$110K |
| 88342 |
|
7,114 |
6,320 |
$89K |
| 88264 |
|
1,646 |
1,532 |
$72K |
| 88360 |
|
3,578 |
2,899 |
$69K |
| 88291 |
|
5,742 |
5,345 |
$38K |
| 88121 |
|
224 |
193 |
$17K |
| 88313 |
|
720 |
579 |
$12K |
| 81455 |
|
38 |
32 |
$11K |
| 88120 |
|
86 |
79 |
$10K |
| 88365 |
|
242 |
201 |
$6K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
450 |
359 |
$6K |
| 85060 |
|
354 |
318 |
$5K |
| 85097 |
|
239 |
212 |
$5K |
| 88323 |
|
140 |
118 |
$4K |
| 81206 |
|
288 |
258 |
$4K |
| 81270 |
|
197 |
182 |
$2K |
| 88364 |
|
50 |
41 |
$2K |
| 81279 |
|
74 |
70 |
$2K |
| 88182 |
|
51 |
44 |
$1K |
| 81207 |
|
163 |
144 |
$1K |
| 88311 |
|
416 |
334 |
$855.01 |
| 88188 |
|
13 |
13 |
$400.14 |
| 81403 |
|
28 |
28 |
$382.40 |
| 88280 |
|
14 |
13 |
$193.29 |
| 81479 |
Unlisted molecular pathology procedure |
12 |
12 |
$160.68 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
13 |
13 |
$0.00 |
| 84439 |
|
17 |
17 |
$0.00 |
| 82570 |
|
22 |
22 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
24 |
24 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
61 |
61 |
$0.00 |
| 80061 |
Lipid panel |
76 |
76 |
$0.00 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
19 |
19 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
31 |
31 |
$0.00 |
| 86803 |
|
14 |
14 |
$0.00 |
| 81001 |
|
29 |
29 |
$0.00 |
| 82607 |
|
15 |
15 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
144 |
144 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
24 |
24 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
41 |
41 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
60 |
60 |
$0.00 |
| 82043 |
|
20 |
20 |
$0.00 |
| 86592 |
|
17 |
17 |
$0.00 |
| 82746 |
|
12 |
12 |
$0.00 |
| 80050 |
General health panel |
32 |
32 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
33 |
33 |
$0.00 |
| 85027 |
|
26 |
26 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14 |
14 |
$0.00 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
75 |
75 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
58 |
58 |
$0.00 |